Clinical trial results indicate that Inofer markedly and significantly improved iron uptake, iron saturation and iron stores in patients with heart failure and iron deficiency
Double Bond Pharmaceutical International AB presents the results from a study evaluating Inofer – a medical product against iron deficiency – in patients with heart failure and iron deficiency without having anemia. Current knowledge recommends iron treatment to be given intravenously, as patients with heart failure have so far been regarded to have an insufficient uptake of oral iron treatment. In this pilot study, patients who received oral Inofer (iron succinate) had a markedly and significantly improved iron uptake, with improved iron saturation and iron stores.Iron deficiency occurs in